PM4Onco Oncology The use case PM4Onco ( P ersonalised M edicine for ( 4 ) Onco logy) aims to advance personalised medicine in cancer treatment. For this purpose, a permanent infrastructure is being established [...] validated questionnaires to measure the subjective health status (Patient Reported Outcome = PRO) play a decisive role in assessing quality of life and the success of treatment. This information is currently

Kropp, K.A., Kirchner, M., Plückebaum, N., Selich, A., Serrero, M., Dhingra, A., Cabrera, J.R., Ritter, B., Bauerfeind, R., Wyler, E., Landthaler, M., Schambach, A., Sodeik, B., Mertins, P., and Viej [...] TM., Yu, P., Kalmbach, N., Ritter, B., Eggenschwiler, R., Ouwendijk, WJD., Mzinza, D., Tan, L., Leffler, A., Spohn, M., Brown, RJP., Kropp, KA., Kaever, V., Ha, T-C., Narayanan, P., Grundhoff, A., Förster [...] Förster, R., Schambach, A., Verjans, GMGM., Schmidt, M., Kispert, A., Cantz, T., Gomis, A., Wegner, F., and Viejo-Borbolla, A. 2021. Generation of hiPSC-derived low threshold mechanoreceptors containing axonal

Long-Lasting Immunity Against SARS-Cov-2: Dream or Reality? Gussarow D, Bonifacius A, Cossmann A, Stankov MV, Mausberg P, Tischer-Zimmermann S, Gödecke N, Kalinke U, Behrens GMN, Blasczyk R, Eiz-Vesper B [...] antiviral T cell function despite declining humoral responses Bonifacius A, Tischer-Zimmermann S, Dragon AC, Gussarow D, Vogel A, Krettek U, Gödecke N, Yilmaz M, Kraft ARM, Hoeper MM, Pink I, Schmidt JJ [...] ACT-COVID19-Study A Phase I/ Randomized Phase II Trial To Analyse Safety And Efficacy Of Human SARS-COV-2-Specific T Lymphocyte Transfer In Patients With COVID-19 In Need Of Treatment Or At Risk Of Severe

Kronen P, Hilbe M, Reinisch A, Strunk D, Haverich A, Hoerstrup S, Luescher TF, Kaufmann PA, Landmesser U*, Martin U*: Transplantation and tracking of human-induced pluripotent stem cells in a pig model [...] the body, has opened novel opportunities for the regeneration of damaged organs, for example after a heart attack. Major progress has been achieved over the past years with respect to the potential therapeutic [...] In the present study, the research team led by Professor Dr. Ulrich Martin - in collaboration with a group from Zürich - artificially introduced an ion channel into human iPS cells. Physiological occurrence

Schadzek, P., Roger, Y., Hoffmann, A. (2020): Regeneration of Damaged Tendon-Bone Junctions (Entheses): TAK1 as a Potential Node Factor. Int J Mol Sci;21:E5177. Lavrentieva, A.*, Hoffmann, A.*, Lee-Thedieck [...] publish the scientific results of a joint research project in a renowned journal, "Cytotherapy", and offers a lecture series for students. Signaling pathways in regeneration: A molecular mechanism for tendon [...] Stromal Cells. Cells;9(7):E1580 Winkel, A., Jaimes, Y., Melzer, C., Dillschneider, P., Hartwig, H., Stiesch, M., von der Ohe, J., Strauss, S., Vogt, P.M., Hamm, A., Burmeister, L., Roger, Y., Elger, K.

schools, from now on the training will take place as a degree course at a university. The entry requirement for midwifery training will be raised to a twelve-year general school education. The state examination [...] module each The bachelor's programme in midwifery (B.Sc.) lasts a total of three and a half years. Each of the seven semesters includes a practical module, which is completed at one of the cooperating practical [...] explains MHH President Professor Dr. Michael P. Manns. Bachelor's programme in midwifery The new Bachelor's programme in Midwifery Science at the MHH is a training-integrated undergraduate Bachelor's programme

M, Nayak A , Steffen W, Tsiavaliaris G, Scholz T, Brenner B (2019) Transformation of the Nonprocessive Fast Skeletal Myosin II into a Processive Motor. Small 15: e1804313 Nayak A *, Reck A, Morsczeck [...] Funahashi A, Draviam VM (2015) A proteomic study of mitotic phase-specific interactors of EB1 reveals a role for SXIP-mediated protein interactions in anaphase onset. Biol Open 4: 155-69 Nayak A , Muller [...] Cachexia Sarcopenia Muscle 16: e13776 Khan B, Lanzuolo C, Rosti V, Santarelli P, Pich A, Kraft T, Amrute-Nayak M, Nayak A * (2024) Sorafenib induces cachexia by impeding transcriptional signaling of the

adults. Our current events 24th Conference on Kidney Transplantation November 15, 2025, 9:00 a.m. - 1:00 p.m. 208th Summer Conference of the NDCH e.V. June 24–26, 2026, at Medical Park Hannover; further [...] care, this enables us to offer you state-of-the-art treatment in a gentle and safe manner. Please feel free to contact me personally for a second opinion!" Univ.-Prof. Dr. med. Moritz Schmelzle, Director [...] Donate - Support - Help Support our research with your donation! more information Our team "Treatment at a leading international center... ...safe, gentle and customized for you." "Hannover Medical School (MHH)

Winter semester 2025/26 Lecture series in English language: October 28th - 30th; 2.00 p.m. - 3.30 p.m.; Lecture Hall A (I02-H0-1180): Tuesday, Oct 28th, 2025, Part 1: Introduction and Data Management Wednesday [...] to the Ombuds person. The Ombudsperson will conduct a preliminary review and report about the result to the president of Hannover Medical School. If a suspicion of scientific misconduct cannot be dispelled [...] to the president to open a formal investigation by the Commission of Good Scientific Practice. The Ombudsperson und Deputy Ombudsperson are named by the senate of MHH for a duration of 5 years. Effective

Pägelow D, Chhatbar C, Beineke A, Liu X, Nerlich A, van Vorst K, Rohde M, Kalinke U, Förster R, Halle S, Valentin-Weigand P, Hornef MW, Fulde M. The olfactory epithelium as a port of entry in neonatal ne [...] Halle S, Keyser KA, Stahl FR, Busche A, Marquardt A, Zheng X, Galla M, Heissmeyer V, Heller K, Boelter J, Wagner K, Bischoff Y, Martens R, Braun A, Werth K, Uvarovskii A, Kempf H, Meyer-Hermann M, Arens R [...] Ospina-Quintero L, Ritter C, Schimrock A, Willenzon S, Janssen A, Wagner K, Messerle M, Bošnjak B, Förster R. Protective function of ex vivo-expanded CD8 T cells in a mouse model of adoptive therapy for